EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.70 | (5R)-3,5-bis(6-bromo-1H-indol-3-yl)-5,6-dihydropyrazin-2(1H)-one | IC50: 68.98 mg/L | Staphylococcus aureus | |
3.4.22.70 | (6-methyl-1H-inden-3-yl)[4-(6-methyl-1H-indol-3-yl)-1H-imidazol-2-yl]methanone | IC50: 15.67 mg/Ll | Staphylococcus aureus | |
3.4.22.70 | (6R)-3,6-bis(6-bromo-1H-indol-3-yl)-5,6-dihydropyrazin-2(1H)-one | IC50: 86.34 mg/L | Staphylococcus aureus | |
3.4.22.70 | (6R)-6-(6-bromo-1H-indol-3-yl)-3-(1H-indol-3-yl)-5,6-dihydropyrazin-2(1H)-one | IC50: 34.04 mg/L | Staphylococcus aureus | |
3.4.22.70 | beta-sitosterol-3-O-glucopyranoside | IC50: 18.3 mg/L | Staphylococcus aureus | |
3.4.22.70 | additional information | no inhibition by (3R,6S)-3,6-bis(6-bromo-1H-indol-3-yl)piperazin-2-one and (3R,6S)-3,6-bis(6-bromo-1H-indol-3-yl)piperazin-2-one | Staphylococcus aureus | |
3.4.22.70 | [4-(6-bromo-1H-indol-3-yl)-1H-imidazol-2-yl](1H-indol-3-yl)methanone | IC50: 19.44 mg/L | Staphylococcus aureus | |
3.4.22.70 | [4-(6-bromo-1H-indol-3-yl)-1H-imidazol-2-yl](6-hydroxy-1H-indol-3-yl)methanone | IC50: 16.7 mg/L | Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.22.70 | Staphylococcus aureus | - |
- |
- |
3.4.22.70 | Staphylococcus aureus Newman | - |
- |
- |